A rough patch for J&J – off-label Topomax promotion; Corporate Integrity Agreement (CIA) means “ride-alongs”; OTC product recalls. Ouch.
Glaxo and Novartis dinged by FDA for potentially misleading promotions. More here on the Novartis situation, which involves Gleevec websites.
Intermune gets major setback for lung treatment – InterMune took its best case for pirfenidone to the FDA, and lost. The agency ruled Tuesday afternoon that the developer would need to mount a new clinical trial for the drug before it could provide a green light for marketing…more
Outsourced Training – Sometimes, you don’t have the staffing to meet all the training needs (short-term or long-term). We can help. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
Moving Beyond Blue – my review of a book by an individual struggling with depression, OCD, anxiety, and more.
JUST FOR FUN
Gorgeous pictures of railway bridges. Lots of ’em!
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Leave a Reply